United States: FDA Increases Transparency Of Adverse Event Data For Cosmetics And Foods

ß

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

The timing of this FDA announcement is interesting considering the start of the 115th Congress in January and the pending nature of the Personal Care Products Safety Act.